Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

19 filings reported holding BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 as of Q2 2024.
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.73M shares of 27.8M outstanding shares and own 20.6% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (1.69M shares), JANUS HENDERSON GROUP PLC (901K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (841K shares), Nantahala Capital Management, LLC (841K shares), FRANKLIN RESOURCES INC (797K shares), Schonfeld Strategic Advisors LLC (260K shares), VANGUARD GROUP INC (215K shares), GEODE CAPITAL MANAGEMENT, LLC (64K shares), Simplify Asset Management Inc. (51.2K shares), and BlackRock Inc. (28K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.